Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
VACCINE COMPRISING PERIPHERAL BLOOD MONONUCLEAR CELLS LOADED WITH NATURAL KILLER T CELL LIGAND AND ANTIGEN
Document Type and Number:
WIPO Patent Application WO/2024/058609
Kind Code:
A1
Abstract:
The present invention relates to an immunoprophylactic and therapeutic vaccine comprising peripheral blood mononuclear cells loaded with a natural killer T cell ligand and an antigen, and specifically, to an immunotherapeutic vaccine comprising peripheral blood mononuclear cells loaded with alpha-galactosylceramide, a natural killer T cell ligand and a type of glycolipid. A composition of the present invention is easy to obtain because there is no need to separate specific cells from peripheral blood mononuclear cells. In addition, immunization of peripheral blood mononuclear cells loaded with a natural killer T cell ligand and an antigen not only induces significant levels of activation of natural killer cells and natural killer T cells and cytotoxic T lymphocyte responses, but also has a synergistic effect in the treatment of malignant tumors and thus can be helpfully used as an anticancer immunotherapeutic agent.

Inventors:
KANG CHANG-YUIL (KR)
SONG BOYEONG (KR)
JEON INSU (KR)
Application Number:
PCT/KR2023/013932
Publication Date:
March 21, 2024
Filing Date:
September 15, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CELLID CO LTD (KR)
International Classes:
A61K39/00; A61K35/15; A61K35/17
Foreign References:
KR20090051598A2009-05-22
KR100809873B12008-03-06
KR102122802B12020-06-16
Other References:
KUMAR SUDEEP; SUNAGAR RAJU; PHAM GIANG; GOSSELIN EDMUND J.; NALIN DAVID: "Ex vivoantigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 35, no. 7, 6 January 2017 (2017-01-06), AMSTERDAM, NL , pages 1080 - 1086, XP029904251, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2016.12.035
S. MOTOHASHI, K. NAGATO, N. KUNII, H. YAMAMOTO, K. YAMASAKI, K. OKITA, H. HANAOKA, N. SHIMIZU, M. SUZUKI, I. YOSHINO, M. TANIGUCHI: "A Phase I-II Study of ?-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer", THE JOURNAL OF IMMUNOLOGY, WILLIAMS & WILKINS CO., US, vol. 182, no. 4, 15 February 2009 (2009-02-15), US , pages 2492 - 2501, XP055386155, ISSN: 0022-1767, DOI: 10.4049/jimmunol.0800126
Attorney, Agent or Firm:
LEE, Won Hee (KR)
Download PDF: